Nishadil
Signup Signin
Delhi | 25°C (windy)
A New Chapter for Multiple Sclerosis Treatment: Lupin's Landmark USFDA Approval

A New Chapter for Multiple Sclerosis Treatment: Lupin's Landmark USFDA Approval
Biocon Biologics Secures Landmark USFDA Approval for Critical Antibacterial Drug

Biocon Biologics Secures Landmark USFDA Approval for Critical Antibacterial Drug
Lupin's Latest Triumph: US FDA Greenlight for HIV Drug Ignites Stock Rally

Lupin's Latest Triumph: US FDA Greenlight for HIV Drug Ignites Stock Rally
Market Movers: Unpacking the Buzz Around Top Stocks Today

Market Movers: Unpacking the Buzz Around Top Stocks Today
Load more..